Prof. Jane Nixon
Jane Nixon is Professor of Tissue Viability and Clinical Trials Research and Deputy Director at the Institute of Clinical Trials Research. She gained a Masters in 1996 and PhD in 2001 whilst a senior nurse in the NHS, and moved to the University of Leeds and Deputy Director of the Clinical Trials Research Unit in 2002. Jane has had a longstanding career in clinical trials research, first as an NHS based Chief Investigator and since 2002 as Deputy Director of the Clinical Trials Research Unit.
In the pressure ulcer prevention field Jane has strong national and international collaborations and has undertaken two large multi-centre mattress trials, epidemiological research, systematic reviews of risk factors and quality of life, outcome measurement and instrument development has been involved/led sections of the international US National Pressure Ulcer advisory Panel/European Pressure Ulcer Advisory Panel pressure ulcer prevention guidelines. Jane has secured £5.3 million in research funding for 13 pressure ulcer prevention research awards (including 10 as Chief Investigator). In 2008 Jane led the successful collaborative £2million, 5 year NIHR Programme Grant application entitled Pressure Ulcer PRogranne of ReSEarch (PURPOSE). This included work in pressure ulcer pain, severe pressure ulcers, risk factors, risk assessment, and quality of life, with a strong practice focus. The work is now complete and provides the foundation for practice change over the next 10 years in areas including patient safety, serious incident investigation and patient management. In 2012 Jane was successful in gaining a further NIHR HTA trial grant (£1.8 million) to undertake a third mattress trial comparing high specification foam and alternating pressure mattresses in 3000 high risk patients (PRESSURE 2). The trial is currently recruiting through acute and community NHS Trusts.
Jane is past Chair and current Treasurer of the Tissue Viability Society and Treasurer of the European Pressure ulcer Advisory Panel. She currently serves on national Trial Oversight Committees, is a member of the NIHR Dermatology Specialty Group, Health and Social Care Information Centre Present on Admission Expert Reference Group and the French Clinical Research Infrastructure Network (F-CRIN) Scientific Board.